MedPath
FDA Approval

SENSORCAINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 12, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bupivacaine(7.5 mg in 1 mL)
Epinephrine(0.005 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC

023648251

Products6

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SENSORCAINE MPF

Product Details

NDC Product Code
63323-460
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
EPIDURAL, RETROBULBAR
Effective Date
July 12, 2019
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.2 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 7.5 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.005 mg in 1 mL

SENSORCAINE MPF

Product Details

NDC Product Code
63323-466
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
EPIDURAL, INTRACAUDAL, PERINEURAL
Effective Date
July 12, 2019
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 5 mg in 1 mL

SENSORCAINE MPF

Product Details

NDC Product Code
63323-462
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
EPIDURAL, INTRACAUDAL, PERINEURAL
Effective Date
July 12, 2019
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.2 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 5 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.005 mg in 1 mL

SENSORCAINE

Product Details

NDC Product Code
63323-465
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
INFILTRATION, PERINEURAL
Effective Date
July 12, 2019
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACTQuantity: 1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 2.5 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT

SENSORCAINE

Product Details

NDC Product Code
63323-467
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
PERINEURAL
Effective Date
July 12, 2019
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACTQuantity: 1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 5 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

SENSORCAINE MPF

Product Details

NDC Product Code
63323-464
Application Number
NDA018304
Marketing Category
NDA (C73594)
Route of Administration
INFILTRATION, EPIDURAL, INTRACAUDAL, PERINEURAL
Effective Date
July 12, 2019
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 2.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath